Related Experiment Videos
Natural killer cells and bone marrow transplantation
W J Murphy1, C W Reynolds, P Tiberghien
1Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center, Md 21702-1201.
Journal of the National Cancer Institute
|September 15, 1993
Summary
Natural killer (NK) cells play a dual role in bone marrow transplantation. Understanding NK cell biology is crucial for improving transplant outcomes and overcoming challenges like graft rejection and cancer recurrence.
Area of Science:
- Immunology
- Hematology
- Transplantation Biology
Background:
- Bone marrow transplantation (BMT) treats various cancers and diseases but faces obstacles like graft-versus-host disease (GvHD), graft failure, infections, and cancer recurrence.
- Natural killer (NK) cells are immune cells with diverse functions, increasingly recognized for their complex roles in BMT.
Purpose of the Study:
- To review the literature on NK cell biology and their impact on BMT.
- To reconcile conflicting data on NK cells' beneficial and detrimental effects in BMT.
- To explore NK cells' potential in improving BMT outcomes.
Main Methods:
- Literature review and synthesis of existing research on NK cell biology.
- Analysis of in vitro and in vivo studies on NK cell effects on hematopoiesis.
- Discussion of current challenges in BMT and the role of NK cells.
Main Results:
- NK cells can hinder marrow engraftment (host-derived) or promote it (donor-derived, activated).
- NK cell activity is dependent on their genotype and activation status.
- NK cells influence graft rejection, GvHD, and graft-versus-tumor responses.
Conclusions:
- NK cells have a significant, context-dependent impact on BMT outcomes.
- Targeting NK cell activity could mitigate BMT complications and enhance anti-cancer effects.
- Further research into NK cell biology is essential for optimizing BMT strategies.